Microbot Medical Shares Owned By Institutions vs. Current Valuation

MBOT Stock  USD 1.00  0.02  1.96%   
Taking into consideration Microbot Medical's profitability measurements, Microbot Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Microbot Medical's ability to earn profits and add value for shareholders. Sales General And Administrative To Revenue is likely to gain to about 75.4 K in 2024, whereas Price To Sales Ratio is likely to drop 302.36 in 2024. At this time, Microbot Medical's Non Operating Income Net Other is comparatively stable compared to the past year. Interest Income is likely to gain to about 222.6 K in 2024, despite the fact that Total Other Income Expense Net is likely to grow to (840.8 K).
For Microbot Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Microbot Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Microbot Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Microbot Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Microbot Medical over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.79)
Return On Assets
(0.65)
Return On Equity
(1.34)
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Microbot Medical Current Valuation vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Microbot Medical's current stock value. Our valuation model uses many indicators to compare Microbot Medical value to that of its competitors to determine the firm's financial worth.
Microbot Medical is rated below average in shares owned by institutions category among its peers. It is rated below average in current valuation category among its peers reporting about  1,746,479  of Current Valuation per Shares Owned By Institutions. Comparative valuation analysis is a catch-all technique that is used if you cannot value Microbot Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Microbot Current Valuation vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Microbot Medical

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
7.46 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Microbot Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
13.03 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Microbot Current Valuation vs Competition

Microbot Medical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 332.15 Billion. Microbot Medical adds roughly 13.03 Million in current valuation claiming only tiny portion of equities under Health Care industry.

Microbot Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Microbot Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Microbot Medical will eventually generate negative long term returns. The profitability progress is the general direction of Microbot Medical's change in net profit over the period of time. It can combine multiple indicators of Microbot Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-9.9 M-9.4 M
Income Before Tax-10.7 M-11.3 M
Total Other Income Expense Net-885 K-840.8 K
Net Loss-10.7 M-11.3 M
Income Tax Expense-106.2 M-100.9 M
Net Loss-10.6 M-11.1 M
Non Operating Income Net Other730.5 K802.2 K
Net Loss-15.1 M-15.9 M
Interest Income212 K222.6 K
Net Interest Income212 K222.6 K
Change To Netincome1.2 M1.5 M
Net Loss(1.05)(1.11)
Income Quality 0.79  0.95 
Net Loss(9.16)(8.70)

Microbot Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Microbot Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Microbot Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Microbot Medical's important profitability drivers and their relationship over time.

Use Microbot Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbot Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will appreciate offsetting losses from the drop in the long position's value.

Microbot Medical Pair Trading

Microbot Medical Pair Trading Analysis

The ability to find closely correlated positions to Microbot Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbot Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbot Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbot Medical to buy it.
The correlation of Microbot Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbot Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbot Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbot Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Microbot Medical position

In addition to having Microbot Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beer and Liquor Thematic Idea Now

Beer and Liquor
Beer and Liquor Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Beer and Liquor theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beer and Liquor Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.